These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8949994)

  • 21. 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.
    Kok TC; van der Gaast A; Splinter TA
    Eur J Cancer; 1997 Jan; 33(1):165-6. PubMed ID: 9071918
    [No Abstract]   [Full Text] [Related]  

  • 22. Is interferon-alpha and retinoic acid combination along with radiation superior to chemo-radiation in the treatment of advanced carcinoma of cervix?
    Basu P; Biswas J; Mandal R; Choudhury P
    Indian J Cancer; 2006; 43(2):54-9. PubMed ID: 16790941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
    Wadler S; Schwartz EL; Haynes H; Rameau R; Quish A; Mandeli J; Gallagher R; Hallam S; Fields A; Goldberg G; McGill F; Jennings S; Wallach RC; Runowicz CD
    Cancer; 1997 Apr; 79(8):1574-80. PubMed ID: 9118041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
    Nikolaou AC; Fountzilas G; Daniilidis I
    J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
    Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
    Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Feasibility study: concurrent 13-cis-retinoic acid, alfa-2a interferon and radiotherapy in the treatment of 23 patients with advanced cervix uteri epidermoid carcinoma].
    Paredes Espinoza M; Delgadillo Madrueño F; Paredes Casillas P; Delgadillo Hernández JJ; Ayala Castellanos MM; Alvarez Márquez V; Buenrostro Ahued MA; Arias Castro G
    Ginecol Obstet Mex; 1995 May; 63():205-9. PubMed ID: 7789851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
    Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
    Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma.
    Jaremtchuk AV; Aman EF; Ponce W; Zarbá JJ; Ferro AM; Alvarez R; Vigo SA
    Am J Clin Oncol; 2002 Apr; 25(2):123-5. PubMed ID: 11943887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.
    Eisenhauer EA; Lippman SM; Kavanagh JJ; Parades-Espinoza M; Arnold A; Hong WK; Massimini G; Schleuniger U; Bollag W; Holdener EE
    Leukemia; 1994; 8 Suppl 3():S38-41. PubMed ID: 7808023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
    Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ; Myers J; Goepfert H; Lotan R; Hong WK; Lippman SM
    J Clin Oncol; 2002 Jan; 20(2):364-70. PubMed ID: 11786562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma.
    Toma S; Palumbo R; Vincenti M; Aitini E; Paganini G; Pronzato P; Grimaldi A; Rosso R
    Ann Oncol; 1994 May; 5(5):463-5. PubMed ID: 8075053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 13-cis-retinoic acid and interferon-alpha 2a therapy in locally advanced squamous cell carcinoma of the cervix: p53 alteration, proliferating cell nuclear antigen expression and angiogenesis response.
    Charuruks N; Voravud N; Termrungruanglert W; Lertsanguansinchai P; Tresukosol D; Niruthisard S; Sirisabya N
    J Obstet Gynaecol Res; 1998 Oct; 24(5):335-41. PubMed ID: 9879152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 13-cis retinoic acid and interferon-alpha +/- irradiation in the treatment of squamous-cell carcinomas.
    Hoffmann W; Schiebe M; Hirnle P; Souchon R; Clemens M; Adamietz I; Bamberg M
    Int J Cancer; 1997 Feb; 70(4):475-7. PubMed ID: 9033659
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Blessing JA; Nelson BE; Johnson GA; Fowler WC; Reid GC
    Am J Clin Oncol; 1998 Dec; 21(6):591-4. PubMed ID: 9856661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
    Casali A; Sega FM; Casali M; Serrone L; Terzoli E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):227-9. PubMed ID: 9700585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.
    Eisenhauer EA; Lippman SM; Kavanagh JJ; Parades-Espinoza M; Arnold A; Hong WK; Massimini G; Schleuniger U; Bollag W; Holdener EE
    Leukemia; 1994 Oct; 8(10):1622-5. PubMed ID: 7934156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma.
    Brembeck FH; Schoppmeyer K; Leupold U; Gornistu C; Keim V; Mössner J; Riecken EO; Rosewicz S
    Cancer; 1998 Dec; 83(11):2317-23. PubMed ID: 9840531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.
    Pazdur R; Bready B; Ajani JA; Abbruzzese JL; Markowitz A; Sugarman S; Jones D; Levin B
    Am J Clin Oncol; 1995 Oct; 18(5):436-8. PubMed ID: 7572763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.